|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1215 K STREET, #800 |
Address2 |
|
City | SACRAMENTO |
State | CA |
Zip Code | 95814 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 7747-12
|
||||||||
|
6. House ID# 334020000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Anne O'Rourke |
Date | 7/19/2019 4:40:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
2019 Q2 Lobbying Report - April 1-June 30
H.R.1386, the Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act of 2019
H.R.1385, the State Allowance for a Variety of Exchanges (SAVE) Act
Medicare X-Choice Proposal
H.R. 1384, the Medicare for All Act of 2019
S. 1129 Medicare-for-all national health insurance program
S. 1895 Lower Health Care Costs Act of 2019
H.R. 3630 No Surprises Act
S. 1379/H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act
S. 340/H.R. 965, CREATES Act
H.R. 938 BLOCKING Act of 2019
H.R. 986 Protecting Americans with Preexisting Conditions Act of 2019
H.R. 987 Strengthening Health Care and Lowering Prescription Drug Costs
H.R. 1010 To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force
H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019
H.R. 2062 Overdose Prevention and Patient Safety Act (H.R. 2062)
H.R. 3439 To amend the Internal Revenue Code of 1986 and title XI of the Social Security Act to extend appropriations and transfers to the Patient-Centered Outcomes Research Trust Fund and to extend certain health insurance fees for such transfers, and for other purposes
S. 1173 Emergency Medical Services for Children Program Reauthorization Act of 2019
H.R. 3429, the HEARTS and Rural Relief Act
H.R. 3414 Opioid Workforce Act
H.R. 3417 Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act
H.R. 3107 Improving Seniors Timely Access to Care Act
H.R. 3436 Chronic Care Management Improvement Act
Proposed AWI changes in inpatient prospective payment system proposed rule
Submitted Comment Letters
Ref: QSO-19-13 Hospital - DRAFT ONLY - Guidance for Hospital Co-Location with Other Hospitals or Healthcare Facilities
Subject: DRAFT-QSO-19-12-Hospitals - Clarification of Ligature Risk Interpretive Guidelines
RE: OMB-2019-0002, Request for Comment on the Consumer Inflation Measures Produced by Federal Statistical Agencies; Directive No. 14; Federal Register (Vol. 84, No. 88), May 7, 2019
Subject: CMS-3368-P, Medicare Program; Accrediting Organizations-Changes to Change of Ownership; Proposed Rule, Federal Register (Vol. 84, No. 85), May 2, 2019
SUBJECT: CMS-1716-P, Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals; Proposed Rule, Federal Register (Vol. 84, No. 86) May 3, 2019
SUBJECT: CMS-1710-P, Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2020; Proposed Rule, Federal Register (Vol. 84, No.79), April 24, 2019
SUBJECT: CMS-1718-P, Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities, Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2020 Proposed Rule, Federal Register (Vol. 84, No.80), April 25, 2019
SUBJECT: CMS-1712-P, Medicare Program; FY 2020 Inpatient Psychiatric Facilities Prospective Payment System and Quality Reporting Updates for Fiscal Year Beginning October 1, 2019 (FY 2020); Proposed Rule, Federal Register (Vol. 84, No. 78), April 23, 2019
Subject: CMS-9115-P; Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability and Patient Access for Medicare Advantage Organization and Medicaid Managed Care Plans, State Medicaid Agencies, CHIP Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans in the Federally-Facilitated Exchanges and Health Care Providers; Proposed Rule; and RIN 0955-AA01; 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program; Proposed Rule; Federal Register (Vol. 84, No. 42), March 4, 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anne |
O'Rourke |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |